MENU
Education Stock symbols

(TSX = xxx.TO, TSX-V = xxx.V)

ADG.V - Arcus Development Group Inc
157.95 -3.15 (0%)  
Open: Prev Close:
High: Low:
Volume: Market Cap:
Year High: Year Low:
Stock Technical Analysis
Overall       
Targets Six months: 0.03    One year: 0.03
Supports Support1: 0.02   Support2: 0.01
Resistances Resistance1: 0.03    Resistance2: 0.03 
Pivot Point 0.02 
Moving Averages MA(5): 0.02      MA(20): 0.02 

MA(100): 0.02      MA(250): 0.02 
MACD MACD(12,26):       Signal(12,26,9):  
Stochastic Oscillator %K(14,3): 0.02      %D(3):  
RSI RSI(14): 56.67 
52-Week High: 0.04  Low: 0.01  Change(%): -33.3
Average Volume(K) 3-Month: 1091  10-Days: 50
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
Bollinger Bands Analysis
ADG.V has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to ADG.V's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
Stock Technical Analysis Charts
Company news
Mon, 29 Jan 2024
Gilead Sciences raises stake in cancer-centric Arcus Biosciences to 33% - Reuters.com

Wed, 06 Mar 2024
Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS ... - Business Wire

Mon, 05 Feb 2024
RCUS Stock Quote Price and Forecast - CNN

Mon, 15 Jan 2024
Ed Hadad and Tenderloin Nonprofit to Build SF Apartments - The Real Deal

Tue, 16 Apr 2024
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics - 01Net

Thu, 20 Jul 2023
CASI Pharmaceuticals Acquires Global Intellectual Property Rights to Cleave Therapeutics' VCP/P97 Inhibitor CB-5339 - PR Newswire

Stoxline Canada

Stock Chart Toronto

Option Calculator

Financials
EPS
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Shares Out. (M)
Shares Float (M)
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Valuation
P/E
P/E Growth Ratio
P/BV
P/S
P/CF